<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
- ------------------------------------------------------------------------------
Community Medical Transport, Inc.
- ------------------------------------------------------------------------------
Common Stock, par value $.001
- ------------------------------------------------------------------------------
203744 107
- ------------------------------------------------------------------------------
Jason A. Lawit, Esq., Parker Duryee Rosoff & Haft, P.C., 529 Fifth Avenue,
New York, NY 10017; (212) 878-1724
- ------------------------------------------------------------------------------
July 3, 1997
<PAGE>
SCHEDULE 13D
CUSIP No. 203744 107
- -------------------- --------------------
<TABLE>
<S> <C> <C>
- --------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ronald V. Davis
- --------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) |_|
(b) |_|
- --------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- --------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
PF
- --------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) |_|
- --------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A.
- --------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 376,667
SHARES
----------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
----------------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER
376,667
REPORTING
----------------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER
WITH
- --------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
376,667
- --------------------------------------------------------------------------------------------------------
12 CHECK BOX IF AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* |_|
- --------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.2%
- --------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- --------------------------------------------------------------------------------------------------------
</TABLE>
*SEE INSTRUCTIONS BEFORE FILLING OUT!
INCLUDE BOTH SIDES OF THE COVER PAGE, RESPONSES TO ITEM 1-7
(INCLUDING EXHIBITS) OF THE SCHEDULE, AND THE SIGNATURE ATTESTATION
<PAGE>
Item 1. Security and Issuer
This statement relates to the common stock, $.001 par value, of
Community Medical Transport Inc., a Delaware corporation (the "issuer"), with
its principal executive offices located at 45 Morris Street, Yonkers, New York
10705.
Item 2. Identity and Background
This statement is filed on behalf of Ronald V. Davis. Mr. Davis is a
citizen of the United States of America. His address is 8 Indian Drive, Old
Greenwich, Connecticut, 06870. Mr. Davis' principal occupation is that of
equity investor consultant at Davis Capital LLC which has a principal business
address of 2015 West Main Street, Stamford, Connecticut, 06902.
During the last five years, Mr. Davis has not been convicted in any
proceeding (excluding traffic violations or similar misdemeanors), nor has Mr.
Davis been a party to a civil proceeding of a judicial or administrative body
of competent jurisdiction, and as a result of such proceeding was or is
subject to a judgment, decree or final order enjoining future violations of,
or prohibiting or mandating activities subject to, Federal or State securities
laws or finding any violation with respect to such laws.
Item 3. Source and Amount of Funds or Other Consideration
The consideration used to acquire 166,667 shares of common stock of
the issuer (the "Shares") acquired by Mr. Davis was $500,000. The purchase of
the earlier shares, during which Mr. Davis was a less than 5% shareholder, was
done in the open market. The source of the consideration for the 166,667
shares of common stock of the issuer was personal funds.
Item 4. Purpose of Transaction
The purpose of the acquisition of securities of the issuer is
investment. Mr. Davis does not have any plans or proposals which relate to or
would result in:
(a) The acquisition by any person of additional securities of
the issuer, or the disposition of securities of the issuer;
(b) An extraordinary corporate transaction, such as a merger,
reorganization or liquidation, involving the issuer or any
of its subsidiaries;
(c) A sale or transfer of a material amount of assets of the
issuer or any of its subsidiaries;
<PAGE>
(d) Any change in the present board of directors or management
of the issuer, including any plans or proposals to change
the number or term of directors or to fill any existing
vacancies on the board;
(e) Any material change in the present capitalization or
dividend policy of the issuer;
(f) Any other material change in the issuer's business or
corporate structure including but not limited to, if the
issuer is a registered closed-end investment company, any
plans or proposals to make any changes in its investment
policy for which a vote is required by Section 13 of the
Investment Company Act of 1940;
(g) Changes in the issuer's charter, bylaws or instruments
corresponding thereto or other actions which may impede the
acquisition of control of the issuer by any person;
(h) Causing a class of securities of the issuer to be delisted
from a national securities exchange or to cease to be
authorized to be quoted in an inter-dealer quotation system
of a registered national securities association;
(i) A class of equity securities of the issuer becoming eligible
for termination of registration pursuant to Section 12(g)(4)
of the Securities Exchange Act of 1934; or
(j) Any action similar to any of those enumerated above.
Item 5. Interest in Securities of the issuer
Mr. Davis directly owns 376,667 shares of common stock. This
constitutes 7.2% of the outstanding shares of common stock of the issuer. Mr.
Davis has the sole power to vote and dispose all of such shares. Mr. Davis
acquired the 166,667 shares at a price of $3.00 per share in on July 3,1997 in
a private placement by the issuer.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to Securities of the Issuer.
None.
Item 7. Material to Be Filed as Exhibits.
None.
<PAGE>
Signature
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and
correct.
9/3/97 /s/ Ronald V. Davis
- ----------------------- -----------------------
(Date) (Signature)
/s/ Ronald V. Davis
-----------------------
(Print Name)
